Not checked for notices yet.
CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease
Gamze Ates, Joshua Goldberg, Antonio Currais and 1 more
Redox Biology · 2020
doi:10.1016/j.redox.2020.101648
Cited by papers we hold 5
- Energy metabolism in health and diseases · 2025No notice
- Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes · 2023No notice
- Forsythoside A Mitigates Alzheimer's-like Pathology by Inhibiting Ferroptosis-mediated Neuroinflammation via Nrf2/GPX4 Axis Activation · 2022No notice
- Intracellular amyloid toxicity induces oxytosis/ferroptosis regulated cell death · 2020No notice
- Ferroptosis Mechanisms Involved in Neurodegenerative Diseases · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.